From: Cost-effectiveness of a potential Zika vaccine candidate: a case study for Colombia
 | 0% herd immunity | 8% herd immunity | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
RTA | 10% | 90% | 10% | 90% | ||||||||
 |  | WTP |  | WTP |  | WTP |  | WTP | ||||
R 0 | ICER < 0 | $6610 | $19,832 | ICER < 0 | $6610 | $19,832 | ICER < 0 | $6610 | $19,832 | ICER < 0 | $6610 | $19,832 |
2.2 | $6 | $10 | $16 | $12 | $16 | $29 | $4 | $7 | $13 | $6 | $8 | $14 |
2.8 | $29 | $38 | $53 | $35 | $45 | $66 | $16 | $22 | $35 | $20 | $27 | $45 |